Lupus Forum
@TheLupusForum
A free educational resource for anyone involved in lupus research and treatment. Guided by a global steering committee chaired by @EdVital.
🎥 Missed our recent biomarkers in Lupus research webinar? We've got you covered! The on-demand recording is now available on the Lupus Forum website and our YouTube channel. Watch the full webinar here 👉 lupus-forum.com/podcasts/episo…
👋2025 updates to the #ACR guideline for the treatment of #SLE . Read our free slide summary to see the latest recommendations and good practice statements from ACR. #Lupus It is completely free at lupus-forum.com/publications/1…
Join Professor Ed Vital for our cGAS Pathway Podcast from the Lupus Forum. Hear from Professor Vital alongside Professor Michelle Kahlenberg for this insightful discussion. Tune in here 🔗: lupus-forum.com/podcasts/episo… #Lupus #SLE #Immunology #Autoimmune #cGAS #Biotech #Pharma
Unlock expert knowledge with a free Lupus Forum membership! 🩺 Join today and access a comprehensive library of lupus resources, including the latest research, expert insights, and educational tools. Sign up now! 🔗 lupus-forum.com/register
We’re pleased to have Professor Michelle Kahlenberg as a speaker in our new cGAS Pathway Podcast. 🎬 Joined by Professor Ed Vital, Chair of the Lupus Forum, they evaluate the emerging evidence for the use of cGAS therapies for SLE. Tune in here 🔗: lupus-forum.com/podcasts/episo……
🧐The #ACR publish the second manuscript in their 2-part lupus guideline project, with their recommendations available online in summary now, and the manuscript format due to follow in late 2025. #SLE #Lupus Keep yourself up to date by visiting Lupus Forum for our free slide set…
👉 Our July literature search identified 269 new papers on #lupus! 👀View the results by clicking the link below: ow.ly/atvL50Wtfz7
Hear from Lupus Forum Chair Professor Ed Vital in discussion with Professor Michelle Kahlenberg, as they discuss current understanding of the role of the cGAS pathway in SLE. Tune in now 🔗 youtube.com/watch?v=NOTmYr… #Lupus #SLE #Immunology #AutoimmuneDisease #cGAS #Biotech…
🎥 Missed our recent biomarkers in Lupus research webinar? We've got you covered! The on-demand recording is now available on the Lupus Forum website and our YouTube channel. Watch the full webinar here 👉 lupus-forum.com/podcasts/episo… youtube.com/watch?v=HH41aL…
🎙️ New Lupus Forum Podcast! Professors Ed Vital & Michelle Kahlenberg explore the science behind lupus and the pivotal role of the cGAS pathway in SLE 🧬 🎧 Stream now: lupus-forum.com/podcasts/episo… Supported by Ventus Therapeutics #Lupus #SLE #cGAS #Immunology #MedTwitter
🎧 New Lupus Forum podcast! Professors Ed Vital and Michelle Kahlenberg discuss current understanding of the role of the cGAS pathway in SLE. Stream now: 🔗ow.ly/5JQS50WrcW7 #Lupus #SLE #Autoimmunity #cGAS #Immunology #MedTwitter #Podcast
The #ACR publish a summary of their second manuscript in the 2-part lupus guideline project. #SLE #Lupus Click here to read our summary slides for free: ow.ly/OFAL50Wr8SP
Enhance your understanding of #lupus with our newly uploaded slide deck and literature highlights. Visit the #LupusForum today to access these free resources: 🔗ow.ly/Ip4050Wbnl5
Parodis et al. demonstrate the efficacy of #belimumab in treating #SLE compared to placebo. Find the full summary here: 🔗ow.ly/PncX50WaGr9
Patients with #SLE reported improvements in their health status and health-related quality of life over 4 years of #anifrolumab treatment. Get the full summary of the data here: 🔗ow.ly/ojcW50WaGkZ
👋Head over to Lupus-Forum.com to view the latest slide summaries and keep up to date with highlights of the most recent literature in #SLE.
Parodis et al. report #belimumab more superior to placebo in inducing #BICLA response regardless of baseline glucocorticoid dose at most post-baseline assessments. 🔗ow.ly/ZHHK50WaGfM
The Lupus Forum has added three new paper summaries to the free online library from June’s literature review. 👉Head over to the website to access for free. ow.ly/cZUc50WnyUj #Lupus #SLE
Strand et al. reported anifrolumab data from patients on treatment for #SLE spanning over a 4-year period. Dive into the full results here: 🔗ow.ly/AJYu50WaG98
